Modified MMAF - CAS# 1352202-47-1 Catalog No.:M17472-C cis-22a displays antiproliferative effects on

cis-22a displays antiproliferative effects on T47D human breast cancer cells

InChi: InChI=1S/C43H70O15/c1-20(45)54-32-22(47)18-53-35(31(32)51)57-26-10-12-43-19-42(43)14-13-39(6)33(41(8)11-9-27(58-41)38(4

3-dioxol-4-yl)methoxy]carbonyl}-2-oxo-[1

Smiles: CN(CC1C=CC=CC=1)CCCNC(=O)C1=CC2=C(Cl)C3CCCCC=3N=C2C=C1

90 µM) and HDAC3 (IC50 ~1

Modified MMAF - CAS# 1352202-47-1 Catalog No.:M17472-C cis-22a displays antiproliferative effects onModified MMAF, an ADC cytotoxin, can be used in the synthesis of Antibody drug Conjugate (ADC). Modified MMAF can be used for the targeted treatment of cancer. Product information CAS Number: 1352202 47 1 Molecular Weight: 840. 10 Formula: C45H73N7O8 Chemical Name: (2S) N [(3R, 4S, 5S) 1 [(2S) 2 [(1R, 2R) 2 {[(2S) 3 (1H indol 3 yl) 1 (1, 2 oxazinan 2 yl) 1 oxopropan 2 yl]carbamoyl} 1 methoxy 2 methylethyl]pyrrolidin 1 yl] 3 methoxy 5 methyl 1